GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » Sale Of Investment

Biotest AG (XTER:BIO3) Sale Of Investment : €0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Sale Of Investment?

Biotest AG's sale of investment for the three months ended in Dec. 2024 was €0.0 Mil. It means Biotest AG gained €0.0 Mil from selling investments. Biotest AG's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €0.0 Mil.

Compared with last quarter (€0.0 Mil in Sep. 2024 ), Biotest AG gained the same money from selling investments in Dec. 2024 (€0.0 Mil).


Biotest AG Sale Of Investment Historical Data

The historical data trend for Biotest AG's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Sale Of Investment Chart

Biotest AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.50 - - - -

Biotest AG Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotest AG Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotest AG Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Biotest AG's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotest AG Business Description

Traded in Other Exchanges
Address
Landsteinerstrasse 5, PO Box 10 20 40, Dreieich, DEU, 63303
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.
Executives
Dr. Katrin Bernöster Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke Senior Vice President plasma alliances and proteine supply
Stephan Fleck Vice President Corporate Controlling
Dr. Jörg Schüttrumpf VP Corp. Research &Development
Michael Moritz VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines